Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Navigating the CARES Act Emergency Small Business Funding
Learn about the Coronavirus Aid, Relief and Economic Security (CARES) Act and how you can apply for PPP and EIDL Small Business Administration (SBA) loans.
Navigating the CARES Act Emergency Small Business Funding
The Coronavirus Aid, Relief and Economic Security (CARES) Act includes emergency funds to help small businesses through the COVID-19 crisis.
SEMA Show 2021—Visit the Mitchell Booth
The SEMA Show is the premier automotive specialty products trade event in the world. SEMA draws the industry’s brightest minds and hottest products to one place, the Las Vegas Convention Center.
Harness the Power of Case Management to Succeed in the Year Ahead
Clinical strategies for employers and payers to address the challenges of 2021 while managing return-to-work outcomes and keeping workers’ comp costs in line.
Ask the Pharmacist: Emergency Use Authorization
How Does Emergency Use Authorization Differ from Full Approval of a Treatment or Vaccine? The immediate and urgent changes that a global
Putting the ‘longest year ever’ behind us and looking ahead
Recently we sat down with a number of Coventry leaders and asked them what’s on their minds as we begin the new year.